• Login
    View Item 
    •   Home
    • University of Alaska Fairbanks
    • UAF Graduate School
    • Chemistry and Biochemistry
    • View Item
    •   Home
    • University of Alaska Fairbanks
    • UAF Graduate School
    • Chemistry and Biochemistry
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Scholarworks@UACommunitiesPublication DateAuthorsTitlesSubjectsTypeThis CollectionPublication DateAuthorsTitlesSubjectsType

    My Account

    Login

    First Time Submitters, Register Here

    Register

    Statistics

    Display statistics

    Enhancing tumor antigen presentation with complement targeted liposomes

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Francian_A_2021.pdf
    Size:
    5.716Mb
    Format:
    PDF
    Download
    Author
    Francian, Alexandra
    Chair
    Kullberg, Max
    Kuhn, Thomas
    Committee
    Burkhead, Jason
    Knall, Cindy
    Keyword
    Tumor antigens
    Liposomes
    Immune response
    Antigen presenting cells
    Metadata
    Show full item record
    URI
    http://hdl.handle.net/11122/12612
    Abstract
    Tumor-mediated immune evasion and suppression can be prohibitive to successful cancer treatment and recovery. A defining trait of cancer progression is when tumor cells develop the ability to evade detection by the immune system. Advanced tumors can suppress the presentation of antigens to effector immune cells by secreting regulatory cytokines and by downregulating the expression of major histocompatibility complex I (MHC I) receptors on the surface of tumor cells. Effective anti-tumor immunity requires the processing and persistent presentation of tumor antigens to effector cells. The cells responsible for this are antigen presenting cells (APCs), which initiate the immune response against cancer by engulfing and presenting tumor antigens to effector immune cells. APCs present tumor antigens, which provide specific targets for helper T cells and cytotoxic T lymphocytes, allowing the immune system to distinguish cancer cells from noncancerous cells. There are many different types of tumor antigens, and the increased effort to sequence reactive epitopes and establish a database makes tumor antigen immunotherapy a promising avenue for treatments and vaccines. Immunotherapies have been developed to restore the immune response against tumors without the toxic side effects of chemotherapeutic drugs. This research describes a promising cancer immunotherapy utilizing a liposome nanoparticle that binds to endogenous complement C3 proteins in serum and is internalized by APCs through the complement C3 receptor, resulting in direct delivery of encapsulated compounds. APCs were shown to internalize C3-bound liposomes containing ovalbumin (OVA), a model antigen, resulting in a significant increase in activated T cells that recognize OVA, reduced tumor growth in all mice (n=5), and complete elimination of both treated and distal tumors in two out of five mice (40%). Blood from treated mice had lower percentages of immunosuppressive cells, higher percentages of B cells, and increased anti-OVA IgG1. Collectively, treatment with OVA C3-liposomes is able to induce the activation of both cell-mediated and humoral immune responses. C3-liposomes encapsulating a melanoma tumor antigen, TRP-2, were able to reduce and eliminate established tumors in a melanoma tumor model in 6 out 7 mice (86%), with the addition of checkpoint blockade, anti-CTLA-4, improving the results (tumor reduction in all mice; n=3). C3-liposomes were also able to induce expression of costimulatory molecules and the production of proinflammatory cytokines and factors in targeted APCs. These results indicate that C3-liposome delivery of tumor antigens to APCs initiates a potent and systemic antitumor immune response.
    Description
    Dissertation (Ph.D.) University of Alaska Fairbanks, 2021
    Date
    2021-08
    Type
    Dissertation
    Collections
    Chemistry and Biochemistry

    entitlement

     
    ABOUT US|HELP|BROWSE|ADVANCED SEARCH

    The University of Alaska is an affirmative action/equal opportunity employer, educational institution and provider and prohibits illegal discrimination against any individual.

    Learn more about UA’s notice of nondiscrimination.

    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.